Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Ixazomib to Reduce the Number of HIV DNA Positive Lymphoid Cells

NCT02946047 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02946047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02946047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Ixazomib to Reduce the Number of HIV DNA Positive Lymphoid Cells
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
March 20, 2017
Completion date
August 19, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)